SCHEMBL7030683

SCHEMBL7030683

CCCC1=C(C(C)(C)CC(=O)Oc2ccc(N(CCCl)CCCl)cc2)C(=O)C=C(C)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.35
ERBB2 P04626 3/20 0.35
CA12 O43570 3/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
CA9 Q16790 3/20 0.31
GMNN O75496 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7029176 0.92 PTPN1 (0.34) EGFRERBB2CA12CA1CA2
SCHEMBL7025263 0.87 EGFR (0.34) EGFRERBB2GMNNALDH1A1LMNA
SCHEMBL7030587 0.85 EGFR (0.34) EGFRERBB2CA12CA1CA2
SCHEMBL7639975 0.85 EGFR (0.38) EGFRERBB2GMNNALDH1A1LMNA
SCHEMBL7023727 0.85 EGFR (0.37) EGFRERBB2CA12CA1CA2
SCHEMBL7020871 0.79 EGFR (0.36) EGFRERBB2CA12CA1CA2
SCHEMBL7024459 0.76 CA12 (0.33) EGFRERBB2CA12CA1CA2
SCHEMBL7027358 0.75 EGFR (0.35) EGFRERBB2GMNNALDH1A1LMNA
SCHEMBL7024485 0.75 EGFR (0.34) EGFRERBB2CA12CA1CA2
SCHEMBL7023447 0.75 LMNA (0.36) EGFRERBB2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064253-B1 ANTI-TUMOUR AGENTS ASTRAZENECA AB (SE) 2003-01-29 EP disclosed
US-6346633-B1 TERT-AMINOPHENYLESTER OF ACID ASTRAZENECA AB (SE) 2002-02-12 US disclosed
EP-1064253-A1 ANTI-TUMOUR AGENTS AstraZeneca AB (SE) 2001-01-03 EP disclosed
WO-1999048857-A1 ANTI-TUMOUR AGENTS ASTRAZENECA AB (SE) 1999-09-30 WO disclosed